Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1637 1681
This examiner grants 44% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18365744 | QUALITY CONTROL METHOD | Non-Final OA | GUARDANT HEALTH, INC. |
| 18003412 | AMPLICON COMPREHENSIVE ENRICHMENT | Non-Final OA | William Marsh Rice University |
| 18243581 | METHODS FOR NON-INVASIVE PRENATAL PLOIDY CALLING | Non-Final OA | Natera, Inc. |
| 18220183 | METHODS FOR NON-INVASIVE PRENATAL PLOIDY CALLING | Non-Final OA | Natera, Inc. |
| 18054469 | Dumbbell PCR: A Method To Quantify Specific Small RNA Variants With A Single Nucleotide Resolution At Terminal Sequences | Non-Final OA | Thomas Jefferson University |
| 17360121 | DETECTION OF BACTERIAL (MOLLICUTIES) CONTAMINATION | Non-Final OA | Roche Diagnostics Operations, Inc. |
| 17865671 | RECOMBINASE POLYMERASE AMPLIFICATION REAGENTS AND KITS | Final Rejection | ABBOTT DIAGNOSTICS SCARBOROUGH, INC. |
| 18304282 | AMPLIFICATION OF NUCLEIC ACIDS | Non-Final OA | LumiraDx UK Ltd. |
| 18102031 | NUCLEIC ACID AMPLIFICATION PROCESSES | Final Rejection | LumiraDx UK Ltd. |
| 18176418 | COMPOSITIONS FOR SURFACE AMPLIFICATION AND USES THEREOF | Non-Final OA | Ultima Genomics, Inc. |
| 17886126 | METHODS AND KITS FOR DEPLETING UNDESIRED NUCLEIC ACIDS | Non-Final OA | Revvity Health Sciences, Inc. |
| 18027971 | MULTIPLEX NUCLEIC ACID DETECTION METHOD, COMPOSITION AND KIT | Non-Final OA | MACCURA BIOTECHNOLOGY CO., LTD. |
| 17986339 | BORDETELLA DETECTION ASSAY | Non-Final OA | Quest Diagnostics Investments LLC |
| 17401662 | Methods for Adding Adapters to Nucleic Acids and Compositions for Practicing the Same | Final Rejection | Takara Bio USA, Inc. |
| 17081417 | COMPOSITIONS AND METHODS FOR TARGETED NUCLEIC ACID SEQUENCE ENRICHMENT AND HIGH EFFICIENCY LIBRARY GENERATION | Final Rejection | NUGEN TECHNOLOGIES, INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy